Satsuma Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $59,218,000.
Profit Margin
| 2017 | 0 | -5.17M | |
|---|---|---|---|
| 2018 | 0 | -7.34M | |
| 2019 | 0 | -28.51M | |
| 2020 | 0 | -47.67M | |
| 2021 | 0 | -51.26M | |
| 2022 | 0 | -69.16M |
STSA Income Statement (2017 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 0 | 0 | 0 | 0 | 0 | 0 |
Operating exp. | ||||||
Research and development | 44.09M | 37.63M | 36.27M | 24.19M | 6.43M | 4.19M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 59.21M | 51.16M | 48.32M | 28.88M | 7.51M | 4.94M |
Operating income | -70.94M | -51.16M | -48.32M | -28.88M | -7.51M | -4.94M |
Other income (expenses), net | 892K | -6K | 765K | 706K | 169K | -225K |
Income before tax | -70.05M | -51.17M | -47.56M | -28.17M | -7.34M | -5.17M |
Income tax expense | -892K | 92K | 111K | 340K | 259K | -210K |
Net income | -69.16M | -51.26M | -47.67M | -28.51M | -7.34M | -5.17M |
Earnings per share | ||||||
Basic EPS | -2.16 | -1.76 | -2.74 | -4.86 | -1.86 | -0.76 |
Diluted EPS | -2.16 | -1.76 | -2.74 | -4.86 | -1.86 | -0.76 |
| Data source | Data source | Data source | Data source |